Excerpts from analysts' report

RHB Research analysts: Jarick Seet (left) & Terence Wong, CFA JarickSeet11.14

IPS officially commenced HS-Micro security products co-manufacturing in Singapore, with its main role to source for locally-produced encasing and/or shields, and product assembly.

Maintain BUY with a SGD0.63 TP (31% upside). It also commenced a pilot trial run on the secure virtual health care system and solutions JV at the Kembangan-Chai Chee Seniors Activity Centre. We remain bullish on IPS’ bright outlook.

Commencement of co-manufacturing. As of 1 Apr, IPS Securex (IPS) officially commenced the co-manufacturing of HS-Micro security products in Singapore. Its main role is to source for locally-produced encasing and/or shields, and product assembly.

We expect the scale for co-manufacturing should remain relatively small this year and much bigger next year. It is only expected to have a material impact on the earnings per share and net asset value per share of the group next year.

Trial run for secured virtual healthcare systems and solutions (SVHSS). The SVHSS, a joint-venture (JV) between IPS and Mr Thomas Goh Khoon Lim, recently commenced a trial run at the Kembangan-Chai Chee Seniors Activity Centre for a 6-month period beginning 26 Mar.

The SHVSS enables real-time communication via video conferencing between the centre’s volunteers and the elderly at home who require emergency assistance. In addition, the SVHSS can be equipped with optional capabilities, such as the integration of third-party devices for health monitoring, personnel tracking and many other customisable features, which are beneficial for the healthcare of senior citizens.

Stock price 

48 cents

52-week range

13.25 – 54 cents

PE (ttm)


Estimated P/E (6/2015)


Market cap

S$77.8 m



Dividend yield
Bloomberg data


Maintain BUY with a SGD0.63 TP (post share split). With IPS still expanding its range of products rapidly and going into co-manufacturing, we remain very bullish on this counter due to its unique position in the South-East Asia space.

We continue to expect stellar results ahead as it continues to establish a stable foothold in the homeland security business.

In addition, we are optimistic about more potential contract wins as well on sales of PepperBall Technologies-related products to neighbouring governments, which could bring IPS’ earnings to a whole new level. Maintain BUY with a TP of SGD0.63 (8x FY16F P/E).

♦ A key risk would be if PepperBall contract wins fall below our expectations, which would dent our earnings estimates.

Full report here. 

Share Prices

Counter NameLastChange
AEM Holdings4.0000.040
Avi-Tech Electronics0.275-0.005
Broadway Ind0.141-
China Sunsine0.4500.010
Food Empire0.500-0.005
Fortress Minerals0.3500.010
Geo Energy Res0.3650.010
Golden Energy0.7950.045
GSS Energy0.050-
ISDN Holdings0.430-
IX Biopharma0.131-0.001
Jiutian Chemical0.0770.001
KSH Holdings0.335-
Leader Env0.050-
Medtecs Intl0.109-0.001
Meta Health0.0300.003
Moya Asia0.0890.001
Nordic Group0.490-
Oxley Holdings0.159-0.001
REX International0.225-
Sinostar PEC0.180-
Southern Alliance Mining0.630-
Straco Corp.0.410-
Sunpower Group0.260-
The Trendlines0.083-
Totm Technologies0.1230.001
UG Healthcare0.168-0.001
Uni-Asia Group0.860-0.030
Wilmar Intl3.840-0.020
Yangzijiang Shipbldg1.0300.010

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 918 guests and no members online